Canada purchases 500,000 human H5N1 vaccine doses

Canada purchased half a million doses of a human vaccine for high path avian flu. It is an effort to keep health risks at bay.

Last week an outbreak was reported in a backyard layer poultry farm in Canada.
One infectious disease expert warns with so many cases of seasonal flu popping up, it is likely the two viruses could mix. That would ultimately create a new virus.

According to Matthew Miller, “That process is how all prior flu pandemics, that we’re aware of in the past, have started. Two different influenza viruses infect one host. The avian flu might maintain the severe disease that it causes but gain the ability to spread well between humans the way that seasonal flu can.”

Canada’s Public Health Agency says that risks to the public are still low, but they warn that it is best to stay away from poultry flocks this flu season.

Related Stories
Eric Weaver with UNL joins us to share about a promising new HPAI vaccine, early test results, next steps in development, and its potential impact on the livestock industry.
California almond acreage tightens while pistachios shift into an off-year, shaping a mixed outlook for prices and supply in the tree nut market.
New treatments offer hope, but challenges remain for beekeepers.
Lewis Williamson with HTS Commodities joins us to break down the latest USDA crop progress report, share insights from growers, and discuss how global factors are shaping planting decisions this season.
Growers are making progress with planting despite dry conditions.
House lawmakers push toward a Farm Bill vote as debate grows over E15, Prop 12, and input costs, with farmers seeking certainty and policy updates.